৳ 9,500/unit
Pack: ৳ 9,500
৳ 9,500/unit
Pack: ৳ 9,500
At a glance
Teriparatide is a parathyroid hormone analog (PTH 1-34) used for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture. It stimulates new bone formation.
Indications
- Osteoporosis in postmenopausal women at high risk for fracture
- Bone mass increase in men with primary or hypogonadal osteoporosis at high risk for fracture
- Glucocorticoid-induced osteoporosis in men and women at high risk for fracture
Pharmacology
Teriparatide activates PTH receptors, increasing osteoblastic activity and stimulating new bone formation. Once-daily administration favors bone formation over resorption, increasing bone mineral density and strength.
Dosage
Adult Dose (SC):
- Recommended: 20 mcg subcutaneously once daily
- Treatment duration: Maximum 2 years in a lifetime
Side effects
Common Side Effects:
- Arthralgia (joint pain)
- Pain
- Nausea
Other:
- Hypercalcemia (transient)
- Dizziness (orthostatic hypotension)
- Injection site reactions
Use in pregnancy
Use in Pregnancy: Insufficient data; consider discontinuing teriparatide if pregnancy is recognized; consult your doctor.
Pregnancy Category: C — always consult a doctor before taking during pregnancy.
Precautions & warnings
- Do not use in Paget's disease, pediatric/young adults with open epiphyses, or prior skeletal radiation therapy
- Do not use in bone metastases, history of skeletal malignancies, metabolic bone diseases other than osteoporosis, or hypercalcemic disorders
- Caution in active or recent urolithiasis
- Do not use for more than 2 years in a lifetime
Overdose effects
Overdose may cause hypercalcemia, nausea, dizziness; temporarily discontinue, increase hydration; provide symptomatic treatment.
Storage conditions
Store at 2-8°C in a refrigerator; do not freeze; do not use if frozen; keep out of reach of children.